今开:5.95 | 昨收:6.25 |
最高:6.18 | 最低:5.44 |
涨停价:0.0 | 跌停价:0.0 |
总市值:1.54490723E8 |
产业链观察2023-12-06 20:33
#药闻简讯# 2023 年 12 月 6 日,致力于推进血液恶性肿瘤一线治疗的新护理标准生物制药公司$Syros医药(SYRS)$ 今天宣布了来自其正在进行的 SELECT- 的强有力且令人鼓舞的初步数据 AML-1 2 期试验评估他米巴罗汀(一种口服选择性视黄酸受体 α (RARα) 激动剂)与维奈托克和阿扎胞苷联合治疗新诊断...查看全文
Syros(SYRS)03-27 19:05
$Syros(SYRS)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-24-078195 Act: 33 Size: 66 KB 网页链接查看全文
Syros(SYRS)03-27 18:55
$Syros(SYRS)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-036808 Act: 34 Size: 11 MB 网页链接查看全文
Syros(SYRS)02-14 08:05
$Syros医药(SYRS)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-034118 Act: 34 Size: 100 KB 网页链接查看全文
Syros(SYRS)02-14 08:05
$Syros医药(SYRS)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-034125 Act: 34 Size: 89 KB 网页链接查看全文
Syros(SYRS)02-15 10:05
$Syros医药(SYRS)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001140361-24-008093 Act: 34 Size: 46 KB 网页链接查看全文
Syros(SYRS)02-10 06:15
$Syros医药(SYRS)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-030282 Act: 34 Size: 159 KB 网页链接查看全文
Syros(SYRS)02-14 09:25
$Syros医药(SYRS)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000919574-24-001214 Act: 34 Size: 183 KB 网页链接查看全文
Syros(SYRS)02-07 20:15
$Syros医药(SYRS)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-24-001134 Act: 34 Size: 101 KB 网页链接查看全文
智通财经APP获悉,因塞特(INCY.US)已经终止了与Syros Pharmaceuticals(SYRS.US)在骨髓增生性肿瘤治疗方面的发现和研究合作。终止协议将在8月9日起60天内生效。 2018年1月,因塞特和Syros Pharmaceuticals首次签署了一项合作协议。作为合... 网页链接
$Syros(SYRS)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-24-078195 Act: 33 Size: 66 KB 网页链接
$Syros(SYRS)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-036808 Act: 34 Size: 11 MB 网页链接
$Syros医药(SYRS)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001140361-24-008093 Act: 34 Size: 46 KB 网页链接
$Syros医药(SYRS)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000919574-24-001214 Act: 34 Size: 183 KB 网页链接
$Syros医药(SYRS)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-034118 Act: 34 Size: 100 KB 网页链接
$Syros医药(SYRS)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-034125 Act: 34 Size: 89 KB 网页链接
$Syros医药(SYRS)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-030282 Act: 34 Size: 159 KB 网页链接
$Syros医药(SYRS)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-24-001134 Act: 34 Size: 101 KB 网页链接
$Syros医药(SYRS)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001193125-24-003863 Act: 34 Size: 2 MB 网页链接
$Syros医药(SYRS)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-24-000007 Act: 34 Size: 69 KB 网页链接